Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens.

J Korean Med Sci · 2023 · PMC10226853 · PMID 37270920

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

1 2 In Korea, multidrug-resistant tuberculosis (MDR-TB) showed a decreasing trend of 787, 852, 681, 618, 580, 399, and 371 new patients from 2015 to 2021, and it was estimated that the rapid decrease over the past two years was affected by the pandemic like the global trend. 3 4 5 For MDR-TB treatment, the WHO recommends all-oral regimens, which consists of only oral drugs, incl

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.